Clopidogrel 150 Mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. Results from the Vasp-02 Randomized Study

被引：0
|
作者：
Aleil, Boris [1 ]
Jacquemin, Laurent [2 ]
De Poli, Fabien [3 ]
Zaehringer, Michel [1 ]
Collet, Jean-Philippe [4 ]
Montalescot, Gilles [4 ]
Cazenave, Jean-Pierre [5 ]
Dickele, Marie-Claude [3 ]
Monassier, Jean-Pierre [2 ]
Gachet, Christian [5 ]
机构：
[1] Clin Orangerie, Strasbourg, France
[2] Hop Emile Muller, Mulhouse, France
[3] Ctr Hosp Gen, Haguenau, France
[4] Hop La Pitie Salpetriere, Paris, France
[5] EFS Alsace, INSERM, U311, Strasbourg, France
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S820 / S820
页数：1
相关论文
共 50 条
  • [21] Impact of a 600-mg Loading Dose of Clopidogrel on 30-Day Outcome in Unselected Patients Undergoing Percutaneous Coronary Intervention
    Bonello, Laurent
    Lemesle, Gilles
    De Labriolle, Axel
    Roy, Probal
    Steinberg, Daniel H.
    Slottow, Tina L. Pinto
    Xue, Zhenyi
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10): : 1318 - 1322
  • [22] Impact of a 600-mg Loading Dose of Clopidogrel on 30-Day Outcome in Unselected Patients Undergoing Percutaneous Coronary Intervention
    Bonello, Laurent
    Lemesle, Gilles
    de Labriolle, Axel
    Roy, Probal
    Steinberg, Daniel H.
    Slottow, Tina Pinto
    Xue, Zhenyi
    Torguson, Rebecca
    Kaneshige, Kimberly
    Suddath, William
    Kent, Kenneth
    Setler, Lowell
    Pichard, Augusto
    Waksman, Ron
    CIRCULATION, 2008, 118 (18) : S375 - S375
  • [23] Gene variants in responsiveness to clopidogrel have no impact on clinical outcomes in Chinese patients undergoing percutaneous coronary intervention - A multicenter study
    Li, Chenze
    Zhang, Lina
    Wang, Haoran
    Li, Sha
    Zhang, Yan
    You, Ling
    Sun, Yang
    Wang, Dong
    Yang, Jun
    Cui, Yinghua
    Cao, Yanyan
    Shen, Xiaoqing
    Wang, Yan
    Cui, Wei
    Yan, Jiangtao
    Zeng, Hesong
    Guo, Xiaomei
    Li, Jianjun
    Wang, Dao Wen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 360 - 366
  • [24] A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study
    Palmerini, Tullio
    Barozzi, Chiara
    Tomasi, Luciana
    Sangiorgi, Diego
    Marzocchi, Antonio
    De Servi, Stefano
    Ortolani, Paolo
    Reggiani, Letizia Bacchi
    Alessi, Laura
    Lauria, Giulia
    Bassi, Mirna
    Branzi, Angelo
    THROMBOSIS RESEARCH, 2010, 125 (04) : 309 - 314
  • [25] Atorvastatin pretreatment improves outcome in patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Results of the ARMYDA-ACS randomized trial
    Patti, G.
    Colonna, G.
    Pasceri, V.
    Sardella, G.
    Fischetti, D.
    Miglionico, M.
    Montinaro, A.
    Di Sciascio, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 731 - 731
  • [26] Randomized trial comparing 600-with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment rafter Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial
    Yong, Gerald
    Rankin, Jamie
    Ferguson, Louise
    Thom, Jim
    French, John
    Brieger, David
    Chew, Derek P.
    Dick, Ron
    Eccleston, David
    Hockings, Bernard
    Walters, Darren
    Whelan, Alan
    Eikelboom, John W.
    AMERICAN HEART JOURNAL, 2009, 157 (01) : 60 - U9
  • [27] Impact of smoking on remote ischemic preconditioning in stable angina patients undergoing elective percutaneous coronary intervention: results from the RINC study
    Kajiya, M.
    Miyoshi, T.
    Ejiri, K.
    Nakahama, H.
    Doi, M.
    Munemasa, M.
    Murakami, M.
    Takaishi, A.
    Kawai, Y.
    Sato, K.
    Sato, T.
    Oka, T.
    Nakamura, K.
    Kohno, K.
    Ito, H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 390 - 390
  • [28] Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial
    Zheng, Bo
    Jiang, Jie
    Liu, Huiliang
    Zhang, Jun
    Li, Hui
    Su, Xi
    Wang, Haichang
    Song, Zhiyuan
    Han, Yaling
    Lei, Han
    Cong, Hongliang
    Zhang, Zheng
    Ma, Yitong
    Wang, Jian'an
    Xu, Biao
    Sun, Yingxian
    Gao, Chuanyu
    Zheng, Yang
    Liu, Bin
    Huang, Dejia
    Li, Bao
    Huang, Congxin
    Yang, Tianlun
    Wan, Zheng
    Jia, Shaobin
    Chen, Dafang
    Ge, Junbo
    Huo, Yong
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0B) : B47 - B56
  • [29] Effect of a 180 mg ticagrelor loading dose on myocardial necrosis in patients undergoing elective percutaneous coronary intervention: A preliminary study
    Xu, QuanFu
    Sun, YingGang
    Zhang, Yi
    Liu, Bo
    Fang, Lu
    Shen, ChengXing
    Li, YiGang
    Meng, Shu
    CARDIOLOGY JOURNAL, 2017, 24 (01) : 15 - 24
  • [30] Do low risk patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel need abciximab infusion? Results of ISAR-REACT study
    Gratsianskii, NA
    KARDIOLOGIYA, 2004, 44 (03) : 80 - 81
12345